Stock 531592 GENPHARMASEC LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Genpharmasec Limited

Equities

531592

INE861N01036

Pharmaceuticals

Market Closed - Bombay S.E.
Other stock markets
 06:00:57 2024-06-28 am EDT 		5-day change 1st Jan Change
2.06 INR +1.98% Intraday chart for Genpharmasec Limited +6.19% -55.89%
May. 24 Genpharmasec Limited Reports Earnings Results for the Full Year Ended March 31, 2024 CI
May. 24 Genpharmasec Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024 CI

Valuation

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Capitalization 1 14.67 3,384 2,808 2,218 1,523 861
Enterprise Value (EV) 1 22.98 3,317 2,760 2,074 1,463 855.3
P/E ratio 30.8 x 1,432 x 648 x 173 x -550 x 77.8 x
Yield - - - - - -
Capitalization / Revenue 8.55 x 902 x 17 x 10.4 x 5.57 x 3.37 x
EV / Revenue 13.4 x 884 x 16.7 x 9.74 x 5.36 x 3.35 x
EV / EBITDA 35.6 x -3,807 x 422 x 174 x -281 x 319 x
EV / FCF 16.5 x -313 x -548 x 282 x -33.1 x -19.6 x
FCF Yield 6.06% -0.32% -0.18% 0.35% -3.02% -5.1%
Price to Book -1.7 x 15.7 x 14.8 x 10.7 x 9.91 x 5.62 x
Nbr of stocks (in thousands) 3,260 216,860 216,860 276,860 276,860 276,860
Reference price 2 4.500 15.60 12.95 8.010 5.500 3.110
Announcement Date 10/16/18 9/3/19 11/28/20 9/6/21 9/6/22 9/1/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 1.715 3.751 165 213.1 273.2 255.2
EBITDA 1 0.6452 -0.8715 6.534 11.94 -5.213 2.681
EBIT 1 0.6427 -0.8739 6.485 11.82 -5.355 2.484
Operating Margin 37.48% -23.3% 3.93% 5.55% -1.96% 0.97%
Earnings before Tax (EBT) 1 0.6427 2.93 12.05 15.1 -4.43 2.816
Net income 1 0.4768 2.364 10.09 12.57 -2.093 11.25
Net margin 27.8% 63.02% 6.12% 5.9% -0.77% 4.41%
EPS 2 0.1460 0.0109 0.0200 0.0464 -0.0100 0.0400
Free Cash Flow 1 1.393 -10.61 -5.033 7.355 -44.21 -43.65
FCF margin 81.22% -282.73% -3.05% 3.45% -16.18% -17.11%
FCF Conversion (EBITDA) 215.89% - - 61.58% - -
FCF Conversion (Net income) 292.13% - - 58.49% - -
Dividend per Share - - - - - -
Announcement Date 10/16/18 9/3/19 11/28/20 9/6/21 9/6/22 9/1/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 8.31 - - - - -
Net Cash position 1 - 66.9 48.6 143 59.4 5.74
Leverage (Debt/EBITDA) 12.88 x - - - - -
Free Cash Flow 1 1.39 -10.6 -5.03 7.35 -44.2 -43.6
ROE (net income / shareholders' equity) -5.38% 2.28% 4.97% 6.34% -1.16% 7.33%
ROA (Net income/ Total Assets) 10.8% -0.5% 1.75% 2.81% -1.35% 0.75%
Assets 1 4.413 -473.1 577.6 447.5 154.7 1,504
Book Value Per Share 2 -2.650 1.000 0.8800 0.7500 0.5600 0.5500
Cash Flow per Share 2 0.4800 0.2400 0.1200 0.1300 0.0600 0.0100
Capex - - 0.52 0.12 0.81 0.16
Capex / Sales - - 0.32% 0.06% 0.29% 0.06%
Announcement Date 10/16/18 9/3/19 11/28/20 9/6/21 9/6/22 9/1/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
GENPHARMASEC LIMITED Stock Genpharmasec Limited
-55.89% 13.68M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.32% 815B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+44.05% 641B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.75% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+13.56% 314B
ABBVIE INC. Stock AbbVie Inc.
+10.68% 303B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.57% 242B
NOVARTIS AG Stock Novartis AG
+13.31% 218B
AMGEN INC. Stock Amgen Inc.
+8.48% 168B
PFIZER, INC. Stock Pfizer, Inc.
-2.81% 159B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 531592 Stock
  4. Financials Genpharmasec Limited